fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

Craniopharyngioma

Play Video about video overlay

Craniopharyngioma

A craniopharyngioma is a tumor arising from small nests of cells near the pituitary stalk. Craniopharyngiomas grow slowly and often become large before they are diagnosed. How malignant they are and how quickly they are likely to spread are unknown.

There are two types of craniopharyngiomas: adamantinomatous and papillary. Adamantinomatous craniopharyngioma occurs in children and tends to be less solid than papillary craniopharyngioma. Papillary craniopharyngioma occurs in adults and is a more solid tumor.

Location

Craniopharyngiomas occur in the sellar region of the brain, near the pituitary gland. They often located near the third ventricle, optic nerve, and pituitary gland.

Symptoms

Symptoms common to those diagnosed with craniopharyngioma include visual changes (usually due to pressure on the nearby optic nerve), endocrine changes (similar to pituitary tumors), headache, depression, weight gain, and nausea and vomiting.

Treatment

Surgery to remove the tumor is usually the first step in treatment. If hydrocephalus (excess fluid in the brain) is present, a shunt (drainage system) may be placed during surgery. The shunt will help remove excess cerebrospinal fluid from the brain and ease the pressure.

Radiation therapy may be suggested if all visible tumor cannot be removed. In children younger than three, radiation may be delayed by the use of surgery or hormone therapies.

Craniopharyngiomas tend to be located near the pituitary gland, and pressure on this gland can cause hormone imbalance. To ensure the best outcome, an endocrinologist (a doctor trained to treat hormone imbalances) may work with the treatment team to develop a long-term care plan.

People with BRAF-mutant tumors may benefit from targeted therapy.

Prognosis

Prognosis means a prediction of outcome. This information is usually based on information gathered from groups of people with the same disease. It is important to remember these statistics are not individualized.

The 10-year relative survival rate for craniopharyngioma by age group are as follows:

  • Children (ages 0-14): 92.8%
  • Adolescents and Young Adults (ages 15-39): 88.0%
  • Adults (ages 40+): 72.7%

About half of all patients experience tumor recurrence within 10 years.

Incidence

Over 600 people are diagnosed with a craniopharyngioma in the US each year. Craniopharyngiomas represent approximately 1-3% of all primary brain tumors diagnosed. They are more common in African Americans.

Age Distribution

Craniopharyngiomas account for about 4% of all childhood brain tumors. They tend to be found in two age groups: children aged 5-14 and adults between 50-75.

Risk Factors

There are no known risk factors for craniopharyngioma.

Molecular Profile

Molecular profiling is the detection of specific genes, proteins, or other molecules in a tumor. This information helps confirm tumor diagnosis, inform treatment options, and predict prognosis.

Molecular markers common to adamantinomatous craniopharyngiomas include Wnt-signaling pathway activation and CTNNB1. Markers common to papillary cranipharyngiomas include the BRAF V600E mutation.

Content last reviewed:

Jan 2023 by Navid Redjal, MD, FAANS

Newly diagnosed?
Start here.

This free “Newly Diagnosed Toolkit” has what you need to get started, including diagnosis, treatment,  tumor-specific information for some tumor types, even a custom notebook and pen to keep track of information from your doctor visits.

Subscribe to MindMatters

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Our Support Services are 100% free for patients and caregivers

CareLine

800-886-ABTA (2282) 8:30 AM-5:00 PM CST or info@abta.org
- Information on treatment and care
- Finding brain tumor treatment centers
- Financial assistance resources
- Finding clinical trials

Support Groups

From diagnosis, surgery, and treatment side effects, to recovery and for some—recurrence—you may feel anxious and isolated. Support groups can improve your emotional well-being and quality of life. Virtual and in-person options.

Patient & Caregiver Mentor Support

Our Mentor Program offers patients and caregivers the opportunity to connect with someone who has gone through a similar brain tumor diagnosis, treatment, and care.

Financial Support

Being diagnosed with a brain tumor takes a toll physically, emotionally, and financially. Medical bills and related costs can quickly add up. We have a list of resources to help in addition to the ABTA Financial Assistance Program.

Webinars

The free educational webinar series is an excellent resource for brain tumor patients and caregivers to learn more about brain tumor types, treatments, well-being topics, and research updates from nationally recognized experts.

Educational Resources

- About Brain Tumors
- Questions to Ask Your Doctor
- Tumor-specific educational materials
- Caregiver Handbook
- Clinical Trials
and more

Connections Community

ABTA’s online support community, where brain tumor patients, survivors, and caregivers come together. Information about malignant and non-malignant tumors, GBM, immunotherapy and more.

Patient Family Meetings

Each free, half-day program in this series focuses on a specific topic for brain tumor patients and caregivers, led by nationally recognized experts. Watch one or all. Similar to our Webinars but longer and more in-depth.

Brain Tumor Treatment Center

The ABTA Treatment Center Guide provides detailed information about a variety of treatment centers, including the number of patients treated annually, technologies and specialized procedures offered.

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Your Gift Matched!

Make an end-of-year gift now and your gift will be matched thanks to the family of Connie Fischer.